Filings & corporate actions
47 results filed
CSVNext results · Q2 FY27
Expected 14 Oct 2026 – 15 Nov 2026
Estimate: filed 14–46 days after quarter end, last 5 times
Dividend
₹7.00 per share · last 23 Jun 2026
2026
- 23 JulresultsResults · Q1 FY27 · consolidated and standalone+3.5%NSE
- 14 JulshareholdingShareholding · 30 Jun 2026+5.9%NSE
- 23 JundividendDividend · ₹7.00 per share+2.5%
- 7 MayresultsResults · Q4 FY26 · consolidated and standalone+3.4%NSE
- 13 AprshareholdingShareholding · 31 Mar 2026-0.3%NSE
- 28 JanresultsResults · Q3 FY26 · consolidated and standalone-7.4%NSE
- 19 JanshareholdingShareholding · 31 Dec 2025+2.0%NSE
Reaction to results · all yearsrose on day 0 in 20 of 42 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 23 Jul 2026 | +3.5% | +6.2% | +3.7% | 30.3× |
| Q4 FY26 | 7 May 2026 | +3.4% | -1.8% | +15.0% | 37.3× |
| Q3 FY26 | 28 Jan 2026 | -7.4% | -13.5% | -12.1% | 3.0× |
| Q2 FY26 | 14 Oct 2025 | -2.1% | -1.0% | +23.7% | 67.2× |
| Q1 FY26 | 23 Jul 2025 | +10.9% | +10.0% | +5.5% | 20.9× |
| Q4 FY25 | 23 Apr 2025 | +10.1% | +16.5% | +30.8% | 41.9× |
| Q3 FY25 | 23 Jan 2025 | -3.9% | -2.7% | -12.2% | 5.5× |
| Q2 FY25 | 24 Oct 2024 | +0.7% | +2.9% | +10.9% | 7.8× |
| Q1 FY25 | 24 Jul 2024 | +17.9% | +26.0% | +37.3% | 21.0× |
| Q4 FY24 | 14 May 2024 | +0.6% | -3.2% | +2.2% | 2.3× |
| Q3 FY24 | 2 Feb 2024 | +1.1% | -1.4% | +10.5% | 2.4× |
| Q2 FY24 | 1 Nov 2023 | -0.5% | -1.2% | +1.9% | 0.9× |
| Q1 FY24 | 2 Aug 2023 | -1.3% | -3.2% | -8.9% | 1.0× |
| Q4 FY23 | 24 May 2023 | -1.9% | -3.8% | +12.4% | 3.1× |
| Q3 FY23 | 4 Feb 2023 | -4.4% | -5.2% | -11.6% | 2.4× |
| Q2 FY23 | 12 Nov 2022 | -4.6% | -7.1% | -7.7% | 2.2× |
| Q1 FY23 | 2 Aug 2022 | -0.5% | -0.3% | -0.3% | 0.7× |
| Q4 FY22 | 30 Apr 2022 | -4.9% | -5.8% | -21.3% | 1.0× |
| Q3 FY22 | 14 Feb 2022 | -9.2% | -7.3% | -16.2% | 1.0× |
| Q2 FY22 | 15 Nov 2021 | -0.9% | -5.7% | -9.7% | 1.6× |
| Q1 FY22 | 13 Aug 2021 | -1.5% | -4.2% | -3.9% | 1.2× |
| Q4 FY21 | 10 May 2021 | +0.1% | -3.4% | +0.7% | 0.4× |
| Q3 FY21 | 1 Feb 2021 | +0.9% | +5.3% | +3.7% | 2.8× |
| Q2 FY21 | 30 Oct 2020 | +0.2% | -1.3% | -8.4% | 0.2× |
| Q1 FY21 | 1 Aug 2020 | -3.5% | +1.6% | +7.0% | 1.2× |
| Q4 FY20 | 25 May 2020 | -5.1% | +0.1% | -4.4% | 1.3× |
| Q3 FY20 | 3 Feb 2020 | +8.0% | +7.3% | +7.0% | 6.1× |
| Q2 FY20 | 8 Nov 2019 | -1.9% | +1.5% | +1.9% | 8.2× |
| Q1 FY20 | 12 Aug 2019 | +0.6% | -5.1% | +1.4% | 3.7× |
| Q4 FY19 | 21 May 2019 | +3.5% | +7.8% | +7.9% | 14.0× |
| Q3 FY19 | 19 Feb 2019 | +2.9% | +1.5% | +2.6% | 1.3× |
| Q2 FY19 | 19 Nov 2018 | 0.0% | -3.0% | +2.3% | 0.4× |
| Q1 FY19 | 28 Aug 2018 | +1.4% | +0.6% | -0.3% | 0.9× |
| Q4 FY18 | 20 Jun 2018 | -0.7% | -3.0% | -0.1% | 12.6× |
| Q3 FY18 | 15 Feb 2018 | -0.3% | -2.5% | -6.1% | 0.2× |
| Q2 FY18 | 12 Dec 2017 | +0.1% | -1.7% | +2.2% | 0.6× |
| Q1 FY18 | 23 Aug 2017 | +0.4% | -3.3% | -3.9% | 0.5× |
| Q4 FY17 | 29 May 2017 | -0.7% | +0.3% | +1.8% | 0.2× |
| Q3 FY17 | 30 Jan 2017 | +0.7% | +3.2% | -2.5% | 8.2× |
| Q2 FY17 | 25 Oct 2016 | -0.3% | -2.3% | +1.1% | 0.4× |
| Q1 FY17 | 13 Aug 2016 | +2.4% | +0.3% | +7.9% | 2.9× |
| Q4 FY16 | 17 Jun 2016 | -0.4% | -7.6% | -8.3% | 0.4× |
| Average | +0.3% | -0.2% | +1.5% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSVRevenue YoY+24.3%
Profit YoY+34.1%
Interest cost YoY+18.7%
Revenue QoQ+7.2%
Profit QoQ+5.4%
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +21.5% | +18.0% | +12.2% | +7.8% | +14.9% | +11.2% |
| Profit | +51.9% | +43.2% | +5.5% | +0.8% | +19.2% | +10.2% |
Key data
CSVOpen542.00
Day range528.50 – 544.60
52-week range342.55 – 662.00
From 52w high-20.0%
RSI (14)36.6
ATR (14)17.25
Volume1.57L
Avg volume (20D)2.32L
Rel volume0.67×
Volatility (1Y)39.5%
Turnover₹8.3Cr
SMA 50 / 200579.71 / 483.34
Delivery percentage
Latest · 6 Oct 202659.1%
20-day avg55.9%
1-year avg47.1%
Percentile (own history)78th
Range6.9–95.4%
Sessions1,731
Over the last 20 sessions THYROCARE settled 55.9% of its traded quantity, which is above average for an NSE equity. Its one-year average is 47.1%, so recent sessions are running 8.9 points higher than usual. The latest session ranks higher than 78% of the 1,731 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
IndustryHealthcare Service Provider
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -2.26% | -3.37% | -8.44% | -0.41% | +44.75% | +41.37% |
Valuation
CSVMarket cap₹8,433 Cr
P/E (TTM)47.9
EPS (TTM)11.05
Shares outstanding15.92Cr
Listed9 May 2016
Ownership
CSVPromoter60.92%
Promoter Δ QoQ0.00 pp
Public39.08%
FII5.44%
DII20.92%
Pledged100.00%
Quarterly results · consolidated
CSV| Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 216.5 | 195.5 | 224.0 | 240.0 |
| YoY chg | +22.1% | +17.8% | +19.7% | +24.3% |
| Net profit (₹ Cr) | 47.8 | 28.1 | 48.7 | 51.3 |
| YoY chg | +1.5% | +47.9% | +125.8% | +34.1% |
| Net margin | 22.1% | 14.3% | 21.7% | 21.4% |
| EPS | 3.01 | 1.81 | 2.98 | 3.22 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 60.92% · public 39.08%2021-092026-06
- Promoter
- Public and others
- Promoter
- 60.92%
- Public
- 39.08%
- Promoter change
- 0.00 pp
- Filed
- 14 Jul 2026
- FII
- 5.44%
- DII
- 20.92%
- Promoter pledged
- 100.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV₹ crore, as filed
| Q2 FY24 | Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 148.0 | 134.7 | 154.3 | 156.9 | 177.4 | 165.9 | 187.2 | 193.0 | 216.5 | 195.5 | 224.0 | 240.0 | |
| Other income | 2.2 | 2.7 | 3.5 | 3.6 | 2.6 | 4.0 | 4.6 | 4.7 | 3.1 | 5.0 | 4.3 | 4.2 | |
| Total income | 150.2 | 137.5 | 157.7 | 160.5 | 180.0 | 169.9 | 191.8 | 197.7 | 219.6 | 200.5 | 228.3 | 244.2 | |
| Total expenses | 122.3 | 117.7 | 134.6 | 126.6 | 142.9 | 141.8 | 143.9 | 147.5 | 157.3 | 159.2 | 164.4 | 176.6 | |
| └ Finance costs | 1.1 | 1.1 | 1.1 | 1.0 | 0.8 | 0.6 | 0.7 | 0.8 | 0.6 | (0.1) | 1.5 | 1.4 | |
| └ Depreciation | 10.7 | 13.5 | 13.1 | 11.4 | 13.1 | 17.1 | 13.8 | 11.4 | 11.5 | 21.6 | 14.0 | 12.5 | |
| Profit before tax | 27.9 | 19.8 | 22.9 | 33.9 | 37.1 | 28.1 | 47.8 | 50.2 | 62.3 | 35.1 | 63.9 | 67.6 | |
| Tax expense | 7.9 | 5.2 | 5.7 | 9.6 | (10.4) | 9.0 | 25.6 | 12.2 | 14.8 | 7.3 | 15.7 | 17.0 | |
| Net profit | 20.3 | 14.7 | 17.2 | 23.9 | 47.1 | 19.0 | 21.6 | 38.3 | 47.8 | 28.1 | 48.7 | 51.3 | |
| EPS | 1.28 | 0.93 | 1.18 | 1.51 | 1.66 | 1.19 | 1.39 | 2.45 | 3.02 | 1.82 | 2.99 | 3.23 | |
| Net margin | 13.74% | 10.94% | 11.14% | 15.26% | 26.57% | 11.43% | 11.52% | 19.84% | 22.08% | 14.35% | 21.75% | 21.39% | |
| PBT margin | 18.86% | 14.68% | 14.85% | 21.61% | 20.90% | 16.93% | 25.55% | 26.02% | 28.77% | 17.96% | 28.51% | 28.16% | |
| Tax rate | 28.45% | 26.14% | 24.98% | 28.34% | -27.93% | 31.93% | 53.58% | 24.27% | 23.71% | 20.91% | 24.64% | 25.10% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 23 Jul 2026.
THYROCARE at a glance
- THYROCARE closed at ₹529.8 on 6 Oct 2026, -2.26% on the day, +41.4% over one year, 20.0% below its 52-week high of ₹662.
- Delivery was 59.1% of traded quantity on 6 Oct 2026, the 78th percentile of its own 1,731 sessions with a reading (20-session average 55.9%, 1-year average 47.1%).
- Market capitalisation is ₹8,433 crore at a trailing P/E of 47.9 (trailing EPS ₹11.05).
- Q1 FY27 results (consolidated, filed 23 Jul 2026): revenue ₹240 crore (+24.3% year on year), net profit ₹51 crore (+34.1%); the price moved +3.5% on the first session after.
- Promoters held 60.92% at 30 Jun 2026, unchanged on the previous filing, with 100.00% of promoter shares pledged.
- Q2 FY27 results are expected between 14 Oct 2026 and 15 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVMacro sectorHealthcare
Basic industryHealthcare Service Provider
ISININE594H01019
SeriesEQ
Listed9 May 2016
History from9 May 2016
Sessions2,578
Turnover rank#941
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Healthcare Services
CSV- APOLLOHOSPApollo Hospitals Enterprise Limited7,914.50-0.88%
- MAXHEALTHMax Healthcare Institute Limited902.50-1.58%
- FORTISFortis Healthcare Limited764.00+0.03%
- YATHARTHYatharth Hospital & Trauma Care Services Limited1,058.80+5.56%
- ASTERDMAster DM Quality Care Limited684.70-0.98%
- MANIPALHOSManipal Health Enterprises Limited690.50+3.52%
- LALPATHLABDr. Lal Path Labs Ltd.1,964.20-0.36%
- ARTEMISMEDArtemis Medicare Services Limited318.35-1.77%
- NEPHROPLUSNephrocare Health Services Limited634.55-0.49%
- GKSLGujarat Kidney And Super Speciality Limited193.62+1.72%
- KIMSKrishna Institute of Medical Sciences Limited693.40-1.71%
- NHNarayana Hrudayalaya Ltd.1,723.80+0.08%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE